UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer

Clinical cancer research, 2017-08, Vol.23 (16), p.4780-4792

2017

Volltextzugriff (PDF)

A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer

Scientific reports, 2021-11, Vol.11 (1), p.22242-8, Article 22242

2021

Volltextzugriff (PDF)

Phase I dose‐escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer

Cancer science, 2020-03, Vol.111 (3), p.924-931

2020

Volltextzugriff (PDF)

SY30-1 Topics on basic and translational breast cancer research of early phase clinical trial

Annals of oncology, 2022-07, Vol.33, p.S454

Kogawa, Takahiro

2022

Volltextzugriff (PDF)

Chemoprevention of pancreatic cancer by inhibition of glutathione-S transferase P1

Investigational new drugs, 2021-12, Vol.39 (6), p.1484-1492

2021

Volltextzugriff (PDF)

Safety, pharmacokinetics, and preliminary efficacy of the PARP inhibitor talazoparib in Japanese patients with advanced solid tumors: phase 1 study

Investigational new drugs, 2021-12, Vol.39 (6), p.1568-1576

2021

Volltextzugriff (PDF)

Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)

BMC cancer, 2023-11, Vol.23 (1), p.1-1098, Article 1098

2023

Volltextzugriff (PDF)

Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk

BMC cancer, 2021-10, Vol.21 (1), p.1111-8, Article 1111

2021

Volltextzugriff (PDF)

Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort

European journal of cancer (1990), 2022-06, Vol.168, p.108-118

2022

Volltextzugriff (PDF)

BRACAnalysis and multigene panel testing needs hereditary cancer care

Annals of oncology, 2019-10, Vol.30, p.vi52

Kogawa, Takahiro

2019

Volltextzugriff (PDF)

PD6-3BRACAnalysis and multigene panel testing needs hereditary cancer care

Annals of oncology, 2019-10, Vol.30 (Supplement_6)

Kogawa, Takahiro

2019

Volltextzugriff (PDF)

The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434)

Investigational new drugs, 2021-02, Vol.39 (1), p.152-162

2021

Volltextzugriff (PDF)

The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis

Breast (Edinburgh), 2021-08, Vol.58, p.50-56

2021

Volltextzugriff (PDF)

Mitigation of paclitaxel-induced peripheral neuropathy in breast cancer patients using limb-cooling apparatus: a study protocol for a randomized controlled trial

Frontiers in oncology, 2023-07, Vol.13, p.1216813-1216813

2023

Volltextzugriff (PDF)

EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer

Oncotarget, 2017-09, Vol.8 (40), p.67904-67917

2017

Volltextzugriff (PDF)

Overall survival and post-progression survival are potent endpoint in phase III trials of second/third-line chemotherapy for advanced or recurrent epithelial ovarian cancer

Journal of Cancer, 2018-01, Vol.9 (5), p.872-879

2018

Volltextzugriff (PDF)

Single agent activity of U3-1402, a HER3-targeting antibody-drug conjugate, in breast cancer patients: Phase 1 dose escalation study

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.2512-2512

2018

Volltextzugriff (PDF)

Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers

Breast cancer research : BCR, 2013-11, Vol.15 (6), p.R112-R112, Article R112

2013

Volltextzugriff (PDF)

The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor‐positive breast cancer: A single‐institute retrospective study

Cancer reports, 2023-02, Vol.6 (2), p.e1695-n/a

2023

Volltextzugriff (PDF)

Myocarditis associated with immune-checkpoint inhibitors diagnosed by cardiac magnetic resonance imaging

International cancer conference journal, 2023-04, Vol.12 (2), p.109-114

2023

Volltextzugriff (PDF)

Severe drug eruption after antibiotic administration in patients receiving immune checkpoint inhibitors: A monocentric case series

JEADV clinical practice, 2023-06, Vol.2 (2), p.330-337

2023

Volltextzugriff (PDF)

The role of inflammation in inflammatory breast cancer

Advances in experimental medicine and biology, 2014, Vol.816, p.53

2014

Volltextzugriff (PDF)

Double Extramedullary Plasmacytoma of the Stomach with a Long-term Endoscopic Follow-up

Internal Medicine, 2016/12/15, Vol.55(24), pp.3585-3590

2016

Volltextzugriff (PDF)

Cisplatin and S‐1 for urachal carcinoma: A single‐institution case series

IJU case reports, 2019-05, Vol.2 (3), p.150-154

2019

Volltextzugriff (PDF)

Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer

Case reports in oncological medicine, 2020-01, Vol.2020 (2020), p.1-4

2020

Volltextzugriff (PDF)

1 – 25 von 129

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(115)

Publikationsform

Sprache

Englisch
(115)
Japanisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer

A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer

Phase I dose‐escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer

SY30-1 Topics on basic and translational breast cancer research of early phase clinical trial

Chemoprevention of pancreatic cancer by inhibition of glutathione-S transferase P1

Safety, pharmacokinetics, and preliminary efficacy of the PARP inhibitor talazoparib in Japanese patients with advanced solid tumors: phase 1 study

Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)

Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk

Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort

BRACAnalysis and multigene panel testing needs hereditary cancer care

PD6-3BRACAnalysis and multigene panel testing needs hereditary cancer care

The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434)

The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis

Mitigation of paclitaxel-induced peripheral neuropathy in breast cancer patients using limb-cooling apparatus: a study protocol for a randomized controlled trial

EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer

Overall survival and post-progression survival are potent endpoint in phase III trials of second/third-line chemotherapy for advanced or recurrent epithelial ovarian cancer

Single agent activity of U3-1402, a HER3-targeting antibody-drug conjugate, in breast cancer patients: Phase 1 dose escalation study

Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers

The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor‐positive breast cancer: A single‐institute retrospective study

Myocarditis associated with immune-checkpoint inhibitors diagnosed by cardiac magnetic resonance imaging

Severe drug eruption after antibiotic administration in patients receiving immune checkpoint inhibitors: A monocentric case series

The role of inflammation in inflammatory breast cancer

Double Extramedullary Plasmacytoma of the Stomach with a Long-term Endoscopic Follow-up

Cisplatin and S‐1 for urachal carcinoma: A single‐institution case series

Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer

Suchergebnisse filtern